Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS)

48 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2016.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.67M shares of 100M outstanding shares and own 5.65% of the company stock.
Largest 10 shareholders include FMR LLC (3.53M shares), ORBIMED ADVISORS LLC (350K shares), Tekla Capital Management LLC (310K shares), LAZARD ASSET MANAGEMENT LLC (301K shares), FRANKLIN RESOURCES INC (244K shares), Artal Group S.A. (150K shares), Abingworth LLP (100K shares), venBio Select Advisor LLC (97.1K shares), MILLENNIUM MANAGEMENT LLC (70.7K shares), and MORGAN STANLEY (70.1K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.